TELA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.72 USD | +1.94% |
|
+6.07% | -28.70% |
| 04-15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
| 03-22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 116M | - | - | - | |||
| 184B | ||||||
| 108B | ||||||
| 67.82B | ||||||
| 51.05B | ||||||
| 44.67B |
- Stock Market
- Equities
- TELA Stock
- Charts TELA Bio, Inc.
- Sector Chart
